Showing results (111-120 of 190) with videos related to

Sort By:
Pageof 19
Bioorganic & Medicinal Chemistry Letters|November 11, 2019
A new chemotype with promise against Trypanosoma cruziXiaofang Wang, Monica Cal, Marcel Kaiser, et al.
Frontiers in Cellular and Infection Microbiology|June 14, 2019
Bioactivity of Farnesyltransferase Inhibitors Against <i>Entamoeba histolytica</i> and <i>Schistosoma mansoni</i>Alexandra Probst, Thi N Nguyen, Nelly El-Sakkary, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2015
Inhibitors of methionyl-tRNA synthetase have potent activity against Giardia intestinalis trophozoitesRanae M Ranade, Zhongsheng Zhang, J Robert Gillespie, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
New Class of Antitrypanosomal Agents Based on ImidazopyridinesDaniel G Silva, J Robert Gillespie, Ranae M Ranade, et al.
Bioorganic & Medicinal Chemistry|February 12, 2017
Discovery of N-(2-aminoethyl)-N-benzyloxyphenyl benzamides: New potent Trypanosoma brucei inhibitorsAndriy Buchynskyy, J Robert Gillespie, Matthew A Hulverson, et al.
Molecular and Biochemical Parasitology|March 5, 2003
Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeuticsMichael H Gelb, Wesley C Van Voorhis, Frederick S Buckner, et al.
The Journal of Biological Chemistry|April 6, 2000
Cloning, heterologous expression, and distinct substrate specificity of protein farnesyltransferase from Trypanosoma bruceiF S Buckner, K Yokoyama, L Nguyen, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Triazolopyrimidines and Imidazopyridines: Structure-Activity Relationships and in Vivo Efficacy for TrypanosomiasisPendem Nagendar, J Robert Gillespie, Zackary M Herbst, et al.
Pageof 19